Terms: = Breast cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Treatment
6 results:
1. mnx1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive breast cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract] [Full Text] [Related]
2. Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study.
Di Maio M; Bighin C; Schettini F; Ruelle T; Marandino L; Fabi A; De Angelis C; Giuliano M; De Placido P; De Laurentiis M; Riccardi F; Picotto C; Puglisi F; Del Mastro L; Arpino G;
Breast; 2023 Dec; 72():103583. PubMed ID: 37783133
[TBL] [Abstract] [Full Text] [Related]
3. Impact of procedure type on revisional surgery and secondary reconstruction after immediate breast reconstruction in a population-based cohort.
Johnson L; White P; Holcombe C; O'Donoghue J; Jeevan R; Browne J; Fairbrother P; MacKenzie M; Gulliver-Clarke C; Mohiuddin S; Hollingworth W; Potter S
Br J Surg; 2023 May; 110(6):666-675. PubMed ID: 36998148
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification.
Zhong L; Zhang C; Jia W; Zhang P
Ann Diagn Pathol; 2021 Apr; 51():151700. PubMed ID: 33465722
[TBL] [Abstract] [Full Text] [Related]
5. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing breast Ductal Carcinoma In Situ with Microinvasion].
Wu P; Cui L; Guo BH; Wang YC; Cui JS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
[No Abstract] [Full Text] [Related]
6. Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Witzel I; Loibl S; von Minckwitz G; Eidtmann H; Fehm T; Khandan F; Schmatloch S; Hauschild M; Bischoff J; Fasching PA; Mau C; Schem C; Rack B; Meinhold-Heerlein I; Liedtke C; Karn T; Huober J; Zu Eulenburg C; Issa-Nummer Y; Untch M; Müller V
Br J Cancer; 2012 Sep; 107(6):956-60. PubMed ID: 22892393
[TBL] [Abstract] [Full Text] [Related]
